Posted inNews and Updates
New Clinical Trial Standards Emerge for HCC Treatment
Discover how new clinical trial standards for HCC are set to improve research design, patient outcomes, and the development of breakthrough liver cancer drugs.
Posted inNews and Updates
Probiotic Strain KABP051 Linked to Metabolic and Mood Gains
A new clinical study reveals that the probiotic Lactiplantibacillus plantarum KABP051 improves metabolic markers and boosts mood through the gut-brain axis.
Posted inNews and Updates
UniQure Plans Huntington’s Gene Therapy Filing After FDA U-Turn
UniQure is moving toward FDA approval for its Huntington’s gene therapy, AMT-130, following a major regulatory breakthrough in treating the rare condition.
Posted inNews and Updates
New Clinical Trial Identifies Safest Treatment for Staph
A landmark global trial identifies a safer antibiotic standard for Staph aureus bloodstream infections, significantly reducing complications and risks.
Posted inNews and Updates
Diabetic Peripheral Neuropathy Pipeline: 2026 Treatment Outlook
Explore the 2026 DPN pipeline. Discover how Helixmith, Lexicon, and others are developing breakthrough therapies to treat diabetic peripheral neuropathy.
Posted inNews and Updates
Biotech Restrictions: Risks to Global Medical Innovation
Global biotech collaboration faces risks from trade barriers. Discover how restricting international partnerships could stall life-saving medical innovation.
Posted inNews and Updates
Top Antibiotics for Staph Bloodstream Infections Revealed
New global clinical trial findings identify the safest, most effective antibiotic treatments for Staphylococcus aureus bloodstream infections.
Posted inNews and Updates
FDA Approves First Oral Carbapenem Antibiotic for UTIs
The FDA has approved the first oral carbapenem for complicated UTIs. Discover how this shift in antibiotic delivery impacts patient care and resistance.
Posted inNews and Updates
The Rising Risks of Black Market Weight Loss Drugs
Discover the hidden dangers of the booming black market for GLP-1 weight loss drugs. Learn why counterfeit injections pose severe risks to patient safety.
Posted inNews and Updates
Zynlonta Clinical Trial Halted Following Patient Deaths
ADC Therapeutics pauses Zynlonta clinical trials following patient deaths. Learn about the safety concerns surrounding this CD19-targeted cancer therapy.